116 related articles for article (PubMed ID: 26233687)
1. RNAi in murine hepatocytes: the agony of choice--a study of the influence of lipid-based transfection reagents on hepatocyte metabolism.
Böttger J; Arnold K; Thiel C; Rennert C; Aleithe S; Hofmann U; Vlaic S; Sales S; Shevchenko A; Matz-Soja M
Arch Toxicol; 2015 Sep; 89(9):1579-88. PubMed ID: 26233687
[TBL] [Abstract][Full Text] [Related]
2. The efficiency of CD40 down regulation by siRNA and antisense ODN: comparison of lipofectamine and FuGENE6.
Ebadi P; Karimi MH; Pourfathollah AA; Saheb Ghadam Lotfi A; Soheili ZS; Samiee S; Hajati S; Nadali F; Geramizadeh B; Moazzeni SM
Iran J Immunol; 2009 Mar; 6(1):1-11. PubMed ID: 19293472
[TBL] [Abstract][Full Text] [Related]
3. Cell type and transfection reagent-dependent effects on viability, cell content, cell cycle and inflammation of RNAi in human primary mesenchymal cells.
Yang HY; Vonk LA; Licht R; van Boxtel AM; Bekkers JE; Kragten AH; Hein S; Varghese OP; Howard KA; Öner FC; Dhert WJ; Creemers LB
Eur J Pharm Sci; 2014 Mar; 53():35-44. PubMed ID: 24345796
[TBL] [Abstract][Full Text] [Related]
4. Delivery of small interfering RNA to mammalian cells in culture by using cationic lipid/polymer-based transfection reagents.
Brazas RM; Hagstrom JE
Methods Enzymol; 2005; 392():112-24. PubMed ID: 15644178
[TBL] [Abstract][Full Text] [Related]
5. Application of RNA interference to improve mechanistic understanding of omics responses to a hepatotoxic drug in primary rat hepatocytes.
Adler M; Leich E; Ellinger-Ziegelbauer H; Hewitt P; Dekant W; Rosenwald A; Mally A
Toxicology; 2014 Dec; 326():86-95. PubMed ID: 25456269
[TBL] [Abstract][Full Text] [Related]
6. Comparison between Lipofectamine RNAiMAX and GenMute transfection agents in two cellular models of human hepatoma.
Berardo C; Siciliano V; Di Pasqua LG; Richelmi P; Vairetti M; Ferrigno A
Eur J Histochem; 2019 Aug; 63(3):. PubMed ID: 31455073
[TBL] [Abstract][Full Text] [Related]
7. Lipid-based transfection reagents can interfere with cholesterol biosynthesis.
Danielli M; Marinelli RA
Anal Biochem; 2016 Feb; 495():1-2. PubMed ID: 26656923
[TBL] [Abstract][Full Text] [Related]
8. Small interfering RNA (siRNA) delivery into murine bone marrow-derived dendritic cells by electroporation.
Jantsch J; Turza N; Volke M; Eckardt KU; Hensel M; Steinkasserer A; Willam C; Prechtel AT
J Immunol Methods; 2008 Aug; 337(1):71-7. PubMed ID: 18514219
[TBL] [Abstract][Full Text] [Related]
9. Commercially available transfection reagents and negative control siRNA are not inert.
Kleefeldt JM; Pozarska A; Nardiello C; Pfeffer T; Vadász I; Herold S; Seeger W; Morty RE
Anal Biochem; 2020 Oct; 606():113828. PubMed ID: 32745542
[TBL] [Abstract][Full Text] [Related]
10. Efficient and gentle siRNA delivery by magnetofection.
Ensenauer R; Hartl D; Vockley J; Roscher AA; Fuchs U
Biotech Histochem; 2011 Aug; 86(4):226-31. PubMed ID: 20297946
[TBL] [Abstract][Full Text] [Related]
11. Chemical modifications on siRNAs avoid Toll-like-receptor-mediated activation of the hepatic immune system in vivo and in vitro.
Broering R; Real CI; John MJ; Jahn-Hofmann K; Ickenstein LM; Kleinehr K; Paul A; Gibbert K; Dittmer U; Gerken G; Schlaak JF
Int Immunol; 2014 Jan; 26(1):35-46. PubMed ID: 24065781
[TBL] [Abstract][Full Text] [Related]
12. RNAi Transfection Results in Lipidome Changes.
Özbalci C; Storck EM; Eggert US
Proteomics; 2019 Jul; 19(13):e1800298. PubMed ID: 31099980
[TBL] [Abstract][Full Text] [Related]
13. Hepatic cell-to-cell transmission of small silencing RNA can extend the therapeutic reach of RNA interference (RNAi).
Pan Q; Ramakrishnaiah V; Henry S; Fouraschen S; de Ruiter PE; Kwekkeboom J; Tilanus HW; Janssen HL; van der Laan LJ
Gut; 2012 Sep; 61(9):1330-9. PubMed ID: 22198713
[TBL] [Abstract][Full Text] [Related]
14. Neuroprotection by biodegradable PAMAM ester (e-PAM-R)-mediated HMGB1 siRNA delivery in primary cortical cultures and in the postischemic brain.
Kim ID; Lim CM; Kim JB; Nam HY; Nam K; Kim SW; Park JS; Lee JK
J Control Release; 2010 Mar; 142(3):422-30. PubMed ID: 19944723
[TBL] [Abstract][Full Text] [Related]
15. Hepatocyte-targeted psiRNA delivery mediated by galactosylated poly(ethylene glycol)-graft-polyethylenimine in vitro.
Nie C; Liu C; Chen G; Dai J; Li H; Shuai X
J Biomater Appl; 2011 Sep; 26(3):255-75. PubMed ID: 20511388
[TBL] [Abstract][Full Text] [Related]
16. Highly efficient SiRNA and gene transfer into hepatocyte-like HepaRG cells and primary human hepatocytes: new means for drug metabolism and toxicity studies.
Laurent V; Glaise D; Nübel T; Gilot D; Corlu A; Loyer P
Methods Mol Biol; 2013; 987():295-314. PubMed ID: 23475687
[TBL] [Abstract][Full Text] [Related]
17. Effects of linoleate on cell viability and lipid metabolic homeostasis in goose primary hepatocytes.
Pan Z; Wang J; Tang H; Li L; Lv J; Han C; Xia L; Xu F
Comp Biochem Physiol A Mol Integr Physiol; 2011 Jun; 159(2):113-8. PubMed ID: 21295151
[TBL] [Abstract][Full Text] [Related]
18. High throughput RNAi assay optimization using adherent cell cytometry.
Nabzdyk CS; Chun M; Pradhan L; Logerfo FW
J Transl Med; 2011 Apr; 9():48. PubMed ID: 21518450
[TBL] [Abstract][Full Text] [Related]
19. A study of the suppressive effect on human pancreatic adenocarcinoma cell proliferation and angiogenesis by stable plasmid-based siRNA silencing of c-Src gene expression.
Zhao X; Li DC; Zhao H; Li Z; Wang JX; Zhu DM; Zhou J; Cen JN
Oncol Rep; 2012 Mar; 27(3):628-36. PubMed ID: 22200682
[TBL] [Abstract][Full Text] [Related]
20. Development of lipid nanoparticle formulations of siRNA for hepatocyte gene silencing following subcutaneous administration.
Chen S; Tam YY; Lin PJ; Leung AK; Tam YK; Cullis PR
J Control Release; 2014 Dec; 196():106-12. PubMed ID: 25285610
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
